×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ALKS – alkermes plc - ordinary shares (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ALKS
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
1/7
04:12 am
alks
AstronauTx appoints experienced biotech executive Adam Rosenberg as Chair of the Board [Yahoo! Finance]
Low
Report
AstronauTx appoints experienced biotech executive Adam Rosenberg as Chair of the Board [Yahoo! Finance]
1/6
07:00 am
alks
Alixorexton Granted Breakthrough Therapy Designation by U.S. FDA for the Treatment of Narcolepsy Type 1
Low
Report
Alixorexton Granted Breakthrough Therapy Designation by U.S. FDA for the Treatment of Narcolepsy Type 1
1/5
09:02 pm
alks
????????????????:2032??90????????CAGR11.5%???????·???????? [CNET News]
Low
Report
????????????????:2032??90????????CAGR11.5%???????·???????? [CNET News]
12/30
04:26 pm
alks
Alkermes to Present at the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
Low
Report
Alkermes to Present at the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
12/30
04:00 pm
alks
Alkermes to Present at the 44th Annual J.P. Morgan Healthcare Conference
Low
Report
Alkermes to Present at the 44th Annual J.P. Morgan Healthcare Conference
12/22
07:08 am
alks
Why Analysts are Rating Alkermes (ALKS) a Buy [Yahoo! Finance]
Low
Report
Why Analysts are Rating Alkermes (ALKS) a Buy [Yahoo! Finance]
12/17
04:32 pm
alks
Alkermes (NASDAQ:ALKS) had its "buy (b-)" rating reaffirmed by analysts at Weiss Ratings.
Low
Report
Alkermes (NASDAQ:ALKS) had its "buy (b-)" rating reaffirmed by analysts at Weiss Ratings.
12/11
04:15 pm
alks
Alkermes (NASDAQ:ALKS) had its "buy (b-)" rating reaffirmed by analysts at Weiss Ratings.
Low
Report
Alkermes (NASDAQ:ALKS) had its "buy (b-)" rating reaffirmed by analysts at Weiss Ratings.
Date
Time
Symbol
Company Name
Action
%Chg
10/28/2025
07:00 am
alks
alkermes plc - ordinary shares
BEAT
Report
-1.1%
alkermes plc - ordinary shares
7/29/2025
07:00 am
alks
alkermes plc - ordinary shares
BEAT
Report
4.5%
alkermes plc - ordinary shares
5/1/2025
07:00 am
alks
alkermes plc - ordinary shares
MISS
Report
6.1%
alkermes plc - ordinary shares
2/12/2025
07:00 am
alks
alkermes plc - ordinary shares
BEAT
Report
3.4%
alkermes plc - ordinary shares
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
1/12
08:01 am
alks
Form 8-K Alkermes plc. For: Jan 12
Low
Report
Form 8-K Alkermes plc. For: Jan 12
1/8
07:38 pm
alks
Form 144 Alkermes plc. Filed by: Hopkinson Craig C.
Low
Report
Form 144 Alkermes plc. Filed by: Hopkinson Craig C.
1/8
05:23 pm
alks
Form 4 Alkermes plc. For: Jan 08 Filed by: Hopkinson Craig C.
Low
Report
Form 4 Alkermes plc. For: Jan 08 Filed by: Hopkinson Craig C.
1/6
07:07 am
alks
Form 8-K Alkermes plc. For: Jan 06
Low
Report
Form 8-K Alkermes plc. For: Jan 06
1/2
04:40 pm
alks
Form 4 Alkermes plc. For: Jan 02 Filed by: Hopkinson Craig C.
Low
Report
Form 4 Alkermes plc. For: Jan 02 Filed by: Hopkinson Craig C.
1/2
04:36 pm
alks
Form 144 Alkermes plc. Filed by: Hopkinson Craig C.
Low
Report
Form 144 Alkermes plc. Filed by: Hopkinson Craig C.
12/5
04:21 pm
alks
Form 4 Alkermes plc. For: Dec 03 Filed by: Hopkinson Craig C.
Low
Report
Form 4 Alkermes plc. For: Dec 03 Filed by: Hopkinson Craig C.
12/3
04:32 pm
alks
Form 144 Alkermes plc. Filed by: Hopkinson Craig C.
Low
Report
Form 144 Alkermes plc. Filed by: Hopkinson Craig C.
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
2/19
Alkermes to Present at the 9th Annual SVB Leerink Global Healthcare Conference
9.4%
3/13 Alkermes Plc (NASDAQ: ALKS) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. 8.8%
7/29 Alkermes Announces Settlement With Amneal Over VIVITROL® Patent Dispute 7.5%
4/3 Form 4 Alkermes plc. For: Apr 02 Filed by: POPS RICHARD F 7.3%
2/18 Form 4 Alkermes plc. For: Feb 16 Filed by: LANDINE MICHAEL J 7.2%
7/30 Form 8-K Alkermes plc. For: Jul 26 6.0%
2/5 Form SC 13G/A Alkermes plc. Filed by: BlackRock Inc. 5.1%
12/4 Form CT ORDER Alkermes plc. 4.7%
9/10 Alkermes (ALKS) Investor Presentation - Slideshow [Seeking Alpha] 4.7%
10/23 Alkermes Plc (NASDAQ: ALKS) had its "hold" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $23.00 price target on the stock, down previously from $25.00. 4.6%
3/13 Alkermes Plc (NASDAQ: ALKS) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. 8.8%
7/29 Alkermes Announces Settlement With Amneal Over VIVITROL® Patent Dispute 7.5%
4/3 Form 4 Alkermes plc. For: Apr 02 Filed by: POPS RICHARD F 7.3%
2/18 Form 4 Alkermes plc. For: Feb 16 Filed by: LANDINE MICHAEL J 7.2%
7/30 Form 8-K Alkermes plc. For: Jul 26 6.0%
2/5 Form SC 13G/A Alkermes plc. Filed by: BlackRock Inc. 5.1%
12/4 Form CT ORDER Alkermes plc. 4.7%
9/10 Alkermes (ALKS) Investor Presentation - Slideshow [Seeking Alpha] 4.7%
10/23 Alkermes Plc (NASDAQ: ALKS) had its "hold" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $23.00 price target on the stock, down previously from $25.00. 4.6%
TOP News Decliners
4/29
Form 10-Q Alkermes plc. For: Mar 31
-15.2%
7/25 Alkermes Plc Reports Second Quarter 2019 Financial Results -12.6%
2/13 Form 10-K Alkermes plc. For: Dec 31 -8.5%
3/19 Form 4 Alkermes plc. For: Mar 19 Filed by: POPS RICHARD F -7.3%
4/30 Alkermes Plc (NASDAQ: ALKS) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $23.00 price target on the stock, down previously from $25.00. -6.9%
9/23 Form 4 Alkermes plc. For: Sep 19 Filed by: POPS RICHARD F -4.7%
10/23 Alkermes PLC (ALKS) Q3 2019 Earnings Call Transcript [The Motley Fool] -4.4%
5/13 Alkermes to Showcase Leadership in Schizophrenia With New Data Presentations at Upcoming Scientific Conferences -4.4%
7/18 Alkermes to Host Conference Call to Discuss Second Quarter 2019 Financial Results -4.2%
5/22 Form 8-K Alkermes plc. For: May 22 -4.0%
7/25 Alkermes Plc Reports Second Quarter 2019 Financial Results -12.6%
2/13 Form 10-K Alkermes plc. For: Dec 31 -8.5%
3/19 Form 4 Alkermes plc. For: Mar 19 Filed by: POPS RICHARD F -7.3%
4/30 Alkermes Plc (NASDAQ: ALKS) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $23.00 price target on the stock, down previously from $25.00. -6.9%
9/23 Form 4 Alkermes plc. For: Sep 19 Filed by: POPS RICHARD F -4.7%
10/23 Alkermes PLC (ALKS) Q3 2019 Earnings Call Transcript [The Motley Fool] -4.4%
5/13 Alkermes to Showcase Leadership in Schizophrenia With New Data Presentations at Upcoming Scientific Conferences -4.4%
7/18 Alkermes to Host Conference Call to Discuss Second Quarter 2019 Financial Results -4.2%
5/22 Form 8-K Alkermes plc. For: May 22 -4.0%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: